Examination of the most cutting-edge therapies available for the treatment of retinoblastoma

Main Article Content

Dr Salman Sohail ,Muhammad Sarim Khan ,Dr Shahbaz Ali ,Dr Abdullah Irfan ,Dr Muhammad Shuja Ur rehman,Dr Adeel Chaudhry ,Dr Nauman Ahmed

Keywords

treatment, oncology, retinoblastoma, algorithm, tumor

Abstract

The International Classification of Retinoblastoma (ICRB) staging, the presence or absence of genetic mutations, family psychological factors and cultural attitudes, and accessible institutional resources all have a role in the management of retinoblastoma, making it a difficult disease to treat. Institutional support must be considered in this therapy. PubMed was combed for reports on retinoblastoma and related treatments, such as chemo, chemo reduction, laser, cryotherapy, intravenous chemo, intra arterial chemo, intravitreal chemo, plaque radiation, ophthalmic artery chemosurgery, intracameral chemo, transpupillary thermotherapy, radiation, external beam radiation, and brachytactic

Abstract 80 | PDF Downloads 34

References

1. Global Retinoblastoma Study Group. Global retinoblastoma presentation and analysis by national income level. JAMA Oncol 2020;6:685-95.
2. Mandal, M., Banerjee, I., & Mandal, M. (2022). Nanoparticle-mediated Gene Therapy as a Novel Strategy for the Treatment of Retinoblastoma. Colloids and Surfaces B: Biointerfaces, 112899.
3. Gravino, G. (2022). The pioneering past and cutting-edge future of interventional neuroradiology. Interventional Neuroradiology, 15910199221130234.